Lung cancer epigenetics and genetics
暂无分享,去创建一个
[1] G. Mills,et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.
[2] R. Fergusson. Chapter 41. Lung Cancer , 2008 .
[3] Daniel F. Gudbjartsson,et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.
[4] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[5] Xueyan Zhong,et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer , 2008, Proceedings of the National Academy of Sciences.
[6] F. Schmidt. Meta-Analysis , 2008 .
[7] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[8] C-Y Chen,et al. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case–control study for risk assessment , 2007, The Journal of pathology.
[9] Chein-Hui Hung,et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma , 2007, Cancer.
[10] T. Wall,et al. Differences in pharmacogenetics of nicotine and alcohol metabolism: review and recommendations for future research. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[11] Jude Kendall,et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer , 2007, Proceedings of the National Academy of Sciences.
[12] P. Vineis,et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis. , 2007, Carcinogenesis.
[13] Anthony J Alberg,et al. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[14] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[15] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[16] Ugo Pastorino,et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. , 2007, Cancer letters.
[17] W. Willett,et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.
[18] S. Belinsky,et al. Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools. , 2007, Cancer research.
[19] P. Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.
[20] J. Witte. Multiple prostate cancer risk variants on 8q24 , 2007, Nature Genetics.
[21] K. Robertson,et al. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer , 2007, Oncogene.
[22] David Ryberg,et al. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. , 2007, Lung cancer.
[23] S. Markowitz,et al. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. , 2007, Chest.
[24] A. Whittemore,et al. Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.
[25] M. Esteller. Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.
[26] A. Riggs,et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay , 2007, Proceedings of the National Academy of Sciences.
[27] Jaana M. Hartikainen,et al. A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.
[28] Sandya Liyanarachchi,et al. Aberrant DNA Methylation of OLIG1, a Novel Prognostic Factor in Non-Small Cell Lung Cancer , 2007, PLoS medicine.
[29] M. Spitz,et al. Myeloperoxidase G-463A polymorphism and lung cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens pooled analysis , 2007, Genetics in Medicine.
[30] S. Chanock,et al. Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors , 2007, Cancer Epidemiology Biomarkers & Prevention.
[31] R. Tyndale,et al. Overview of the pharmacogenomics of cigarette smoking , 2007, The Pharmacogenomics Journal.
[32] Paul Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft , 2007 .
[33] Marshall W. Anderson,et al. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. , 2007, Cancer research.
[34] H. Bartsch,et al. Genetic risk profiles for cancer susceptibility and therapy response. , 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[35] G. Peters,et al. Similar chromosomal changes in cisplatin and oxaliplatin‐resistant sublines of the H69 SCLC cell line are not associated with platinum resistance , 2006, Genes, chromosomes & cancer.
[36] W. Gerald,et al. A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.
[37] M. Spitz,et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. , 2006, American journal of epidemiology.
[38] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[39] O. Miettinen,et al. Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .
[40] C. Harris,et al. Radon, secondhand smoke, glutathione‐S‐transferase M1 and lung cancer among women , 2006, International journal of cancer.
[41] S. Leung,et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer , 2006, Nature Genetics.
[42] P. Vineis,et al. Human Genome Epidemiology (huge) Review Xrcc3 and Xpd/ercc2 Single Nucleotide Polymorphisms and the Risk of Cancer: a Huge Review , 2022 .
[43] Pengyuan Liu,et al. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice , 2006, Nature Genetics.
[44] T. Liloglou,et al. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. , 2006, Human molecular genetics.
[45] A. Gylfason,et al. A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.
[46] C. Plass,et al. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. , 2006, Journal of the National Cancer Institute.
[47] J. Danesh,et al. Methods and Findings , 2022 .
[48] Christoph Plass,et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] Y. Nakanishi,et al. EPHX1 Polymorphisms and the Risk of Lung Cancer: A HuGE Review , 2006, Epidemiology.
[50] P. Brennan,et al. Perspectives on the molecular epidemiology of aerodigestive tract cancers. , 2005, Mutation research.
[51] P. Brennan,et al. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. , 2005, American journal of epidemiology.
[52] T. Eisen,et al. Systematic review of the relationship between family history and lung cancer risk , 2005, British Journal of Cancer.
[53] Y. Nakanishi,et al. NQO1, MPO, and the risk of lung cancer: A HuGE review , 2005, Genetics in Medicine.
[54] H. Dienemann,et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. , 2004, Carcinogenesis.
[55] D. Gudbjartsson,et al. Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family , 2004, PLoS medicine.
[56] Marshall W. Anderson,et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.
[57] H. McLeod,et al. Novel human CYP2A6 alleles confound gene deletion analysis , 2004, FEBS letters.
[58] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[59] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[60] David C Christiani,et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines , 2004, Oncogene.
[61] David I. K. Martin,et al. Germline epimutation of MLH1 in individuals with multiple cancers , 2004, Nature Genetics.
[62] Wei-Guo Zhu,et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. , 2003, Human molecular genetics.
[63] M. Meyerson,et al. Missense mutations of the BRAF gene in human lung adenocarcinoma. , 2002, Cancer research.
[64] K. Czene,et al. Attributable risks of familial cancer from the Family-Cancer Database. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[65] Richard Wooster,et al. BRAF and RAS mutations in human lung cancer and melanoma. , 2002, Cancer research.
[66] Shigeki Shimizu,et al. [Molecular abnormalities in lung cancer]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[67] F. Gilliland,et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.
[68] Y. Yatabe,et al. Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers , 2002, Oncogene.
[69] J. Minna,et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Sheu,et al. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. , 2001, Cancer research.
[71] J. Minna,et al. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells , 2001, Oncogene.
[72] J. Minna,et al. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. , 2001, Cancer research.
[73] S. Khuder,et al. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. , 2001, Lung cancer.
[74] P. Lee,et al. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer , 2001, Occupational and environmental medicine.
[75] J. Minna,et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.
[76] A. Gemma,et al. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[77] J. Herman,et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.
[78] J. Radicella,et al. Characterization of the hOGG1 promoter and its expression during the cell cycle. , 2000, Mutation research.
[79] F. Khuri,et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[80] A. Kraus,et al. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] J. Minna,et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.
[82] Eric S. Lander,et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays , 2000, Nature Biotechnology.
[83] Richard Doll,et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.
[84] Chun Xing Li,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.
[85] H. Bartsch,et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[86] J. Herman,et al. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[87] E. Miska,et al. HDAC4 deacetylase associates with and represses the MEF2 transcription factor , 1999, The EMBO journal.
[88] P. Marks,et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.
[89] E. Ballestar,et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.
[90] J. Yokota,et al. How many tumor suppressor genes are involved in human lung carcinogenesis? , 1999, Carcinogenesis.
[91] C. Croce,et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[92] Y. Nakamura,et al. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. , 1999, Cancer research.
[93] P. Shields,et al. Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[94] R. Figlin,et al. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer , 1999, Journal of Cancer Research and Clinical Oncology.
[95] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[96] C. Rubin,et al. Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions , 1998, Annals of Internal Medicine.
[97] E Gabrielson,et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Minna,et al. Progress in understanding the molecular pathogenesis of human lung cancer. , 1998, Biochimica et biophysica acta.
[99] A. Sakurada,et al. The H-cadherin (CDH13) gene is inactivated in human lung cancer , 1998, Human Genetics.
[100] J. Yokota,et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA , 1998, Oncogene.
[101] J. Strouboulis,et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.
[102] E. Wynder,et al. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking , 1997, Cancer.
[103] A. Marchetti,et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. , 1997, Cancer research.
[104] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[105] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[106] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[107] M H Skolnick,et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.
[108] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[109] E. Pollack,et al. What are the odds that smoking will kill you? , 1987, American journal of public health.